Cardiovascular Sciences, Inc. (CVSC)

Market Cap	1.78K -90.5%
Revenue (ttm)	256.68K +849.6%
Net Income	218.97K
EPS	0.01
Shares Out	17.80M
PE Ratio	0.01
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,045
Average Volume	3,203
Open	0.0001
Previous Close	n/a
Day's Range	0.0001 - 0.0001
52-Week Range	0.0000 - 0.0001
Beta	-59.02
RSI	48.17
Earnings Date	n/a

About Cardiovascular Sciences

Cardiovascular Sciences Inc., a technology company, focuses on the development of medical products. Its products include Anti Adhesion Technology products to prevent post surgical scarring; Pyruvate Therapy, a patented method for treating patients suffering from cardiac trauma, such as ischemic reperfusion injury, heart failure, and bypass surgery; Thromboresistant Coating that prevents blood clot formation on medical devices; a biocompatible Human Vascular Tissue Equivalent for artery replacement during heart surgeries; and patented Aortic Cat...

• Industry: Personal Products & Services
• Sector: Consumer Discretionary
• CEO: Larry Hooper
• Employees: 4
• Stock Exchange: OTCMKTS
• Ticker Symbol: CVSC

Financial Performance

In 2008, Cardiovascular Sciences's revenue was $321,662, an increase of 131.41% compared to the previous year's $139,000. Earnings were $169,560, an increase of 14.42%.